Skip to main content

Branded Generic Drugs

Volume 453: debated on Monday 20 November 2006

To ask the Secretary of State for Health (1) when the 2005 consultation on the reimbursement of branded generic drugs is expected to be published; (101667)

(2) what assessment her Department has made of the beneficial effect on National Health Service finances of introducing the proposals for the reimbursement of generic medicine proposed in its recent consultation paper.

Responses to the proposals in this consultation raised a number of complex issues which could not be easily resolved. A decision has therefore been taken to defer any final conclusion until the Department receives the Office of Fair Trading report on the Pharmaceutical Price Regulation Scheme (PPRS) which is expected in the first quarter of 2007.

The Department will not be able to determine what savings may be made by the national health service until such time as the these issues have been resolved.